首页> 外文期刊>Molecular and cellular neurosciences >Autophagy in motor neuron disease: Key pathogenetic mechanisms and therapeutic targets
【24h】

Autophagy in motor neuron disease: Key pathogenetic mechanisms and therapeutic targets

机译:运动神经元疾病中的自噬:关键的发病机制和治疗目标

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Autophagy is a lysosome-dependant intracellular degradation process that eliminates long-lived proteins as well as damaged organelles from the cytoplasm. An increasing body of evidence suggests that dysregulation of this system plays a pivotal role in the etiology and/or progression of neurodegenerative diseases including motor neuron disorders. Herein, we review the latest findings that highlight the involvement of autophagy in the pathogenesis of amyotrophic lateral sclerosis (ALS) and the potential role of this pathway as a target of therapeutic purposes. Autophagy promotes the removal of toxic, cytoplasmic aggregate-prone pathogenetic proteins, enhances cell survival, and modulates inflammation. The existence of several drugs targeting this pathway can facilitate the translation of basic research to clinical trials for ALS and other motor neuron diseases. (C) 2016 Elsevier Inc. All rights reserved.
机译:自噬是一种依赖溶酶体的细胞内降解过程,可消除长寿蛋白以及细胞质中受损的细胞器。越来越多的证据表明,该系统的失调在包括神经运动疾病在内的神经退行性疾病的病因和/或进展中起着关键作用。本文中,我们综述了最新发现,这些发现突出了自噬在肌萎缩性侧索硬化症(ALS)发病机制中的参与以及该途径作为治疗目的的潜在作用。自噬促进去除有毒,易胞质聚集的致病蛋白,提高细胞存活率,并调节炎症。靶向这种途径的几种药物的存在可以促进基础研究到ALS和其他运动神经元疾病的临床试验的转化。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号